171 related articles for article (PubMed ID: 24760723)
1. Risk factors for bleeding in hepatocellular adenoma.
Bieze M; Phoa SS; Verheij J; van Lienden KP; van Gulik TM
Br J Surg; 2014 Jun; 101(7):847-55. PubMed ID: 24760723
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of hepatocellular adenoma with massive bleeding at presentation.
Klompenhouwer AJ; de Man RA; Thomeer MG; Ijzermans JN
World J Gastroenterol; 2017 Jul; 23(25):4579-4586. PubMed ID: 28740346
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of haemorrhage and rupture of hepatocellular adenomas.
van Aalten SM; de Man RA; IJzermans JN; Terkivatan T
Br J Surg; 2012 Jul; 99(7):911-6. PubMed ID: 22619025
[TBL] [Abstract][Full Text] [Related]
4. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience.
Erdogan D; Busch OR; van Delden OM; Ten Kate FJ; Gouma DJ; van Gulik TM
Liver Int; 2006 May; 26(4):433-8. PubMed ID: 16629646
[TBL] [Abstract][Full Text] [Related]
5. Case-orientated approach to the management of hepatocellular adenoma.
van der Windt DJ; Kok NF; Hussain SM; Zondervan PE; Alwayn IP; de Man RA; IJzermans JN
Br J Surg; 2006 Dec; 93(12):1495-502. PubMed ID: 17051603
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study on timing of resection of hepatocellular adenoma.
Klompenhouwer AJ; Bröker MEE; Thomeer MGJ; Gaspersz MP; de Man RA; IJzermans JNM
Br J Surg; 2017 Nov; 104(12):1695-1703. PubMed ID: 28857134
[TBL] [Abstract][Full Text] [Related]
7. Hepatic adenoma and focal nodular hyperplasia.
Shortell CK; Schwartz SI
Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular adenomas and pregnancy].
Bröker ME; van Aalten SM; Ijzermans JN; Dwarkasing RS; Steegers EA; de Man RA
Ned Tijdschr Geneeskd; 2012; 156(38):A5102. PubMed ID: 22992247
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for bleeding hepatocellular adenoma in a United States cohort.
McDermott C; Ertreo M; Jha R; Ko J; Fernandez S; Desale S; Fishbein T; Satoskar R; Winslow E; Smith C; Hsu CC
Liver Int; 2022 Jan; 42(1):224-232. PubMed ID: 34687281
[TBL] [Abstract][Full Text] [Related]
11. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhage caused by ruptured liver cell adenoma following long-term oral contraceptives: a case report.
Meissner K
Hepatogastroenterology; 1998; 45(19):224-5. PubMed ID: 9496518
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of transarterial embolization for hepatocellular adenomas.
van Rosmalen BV; Coelen RJS; Bieze M; van Delden OM; Verheij J; Dejong CHC; van Gulik TM
Br J Surg; 2017 Jun; 104(7):823-835. PubMed ID: 28518415
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatocellular adenoma during pregnancy.
Noels JE; van Aalten SM; van der Windt DJ; Kok NF; de Man RA; Terkivatan T; Ijzermans JN
J Hepatol; 2011 Mar; 54(3):553-8. PubMed ID: 21094555
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.
Julien C; Le-Bail B; Ouazzani Touhami K; Frulio N; Blanc JF; Adam JP; Laurent C; Balabaud C; Bioulac-Sage P; Chiche L
Ann Surg; 2021 Nov; 274(5):843-850. PubMed ID: 34334644
[TBL] [Abstract][Full Text] [Related]
16. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas.
Erdogan D; van Delden OM; Busch OR; Gouma DJ; van Gulik TM
Cardiovasc Intervent Radiol; 2007; 30(6):1252-8. PubMed ID: 17605070
[TBL] [Abstract][Full Text] [Related]
17. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
[TBL] [Abstract][Full Text] [Related]
18. Hepatic adenomas: imaging and pathologic findings.
Grazioli L; Federle MP; Brancatelli G; Ichikawa T; Olivetti L; Blachar A
Radiographics; 2001; 21(4):877-92; discussion 892-4. PubMed ID: 11452062
[TBL] [Abstract][Full Text] [Related]
19. Hepatic tumors induced by sex steroids.
Mays ET; Christopherson W
Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
[TBL] [Abstract][Full Text] [Related]
20. Congenital portosystemic shunts associated with liver tumours.
Pupulim LF; Vullierme MP; Paradis V; Valla D; Terraz S; Vilgrain V
Clin Radiol; 2013 Jul; 68(7):e362-9. PubMed ID: 23537576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
